{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T17:48:34Z","timestamp":1794505714492,"version":"4.9.1"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1R56NS128015"],"award-info":[{"award-number":["1R56NS128015"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1R01NS138402"],"award-info":[{"award-number":["1R01NS138402"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1R01NS133140"],"award-info":[{"award-number":["1R01NS133140"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["5F31NS129265"],"award-info":[{"award-number":["5F31NS129265"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA013330"],"award-info":[{"award-number":["P30 CA013330"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Genome-edited human pluripotent stem cells (hPSCs) provide a powerful platform to study complex diseases such as Parkinson\u2019s disease (PD). Here, we describe iSCORE-PD, an isogenic collection of 65 genome-edited hPSC lines carrying disease-causing or high-risk variants in 11 PD-linked genes (\n                    <jats:italic>SNCA, PRKN, PINK1, DJ1\/PARK7, LRRK2, ATP13A2, FBXO7, DNAJC6, SYNJ1, VPS13C<\/jats:italic>\n                    , and\n                    <jats:italic>GBA1<\/jats:italic>\n                    ). All lines are derived from a well-characterized female hESC line and subjected to extensive quality control. Whole-genome sequencing reveals that genetic variation between lines, largely confined to non-coding regions, is minimal relative to inter-individual differences in patient-derived hiPSCs, with most variation arising from random mutations acquired during cell culture rather than genome-editing-induced off-target effects. Including multiple independently derived clones per mutation can control for this random genetic drift. Our systematic approach ensures high quality of this publicly available iSCORE-PD resource, highlights the advantages of prime editing over conventional CRISPR\/Cas9 methods, and establishes best practices for generating disease-modeling hPSC collections.\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-74355-8","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T19:16:15Z","timestamp":1781723775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["iSCORE-PD: an isogenic stem cell collection to research Parkinson\u2019s disease"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1372-9699","authenticated-orcid":false,"given":"Oriol","family":"Busquets","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanqin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7682-7608","authenticated-orcid":false,"given":"Khaja Mohieddin","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5812-1898","authenticated-orcid":false,"given":"Pilar Alvarez","family":"Jerez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0387-0090","authenticated-orcid":false,"given":"Jesse","family":"Dunnack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riana","family":"Lo Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogendra","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2662-7883","authenticated-orcid":false,"given":"Gabriella R.","family":"Pangilinan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3369-1495","authenticated-orcid":false,"given":"Annika","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannes","family":"Straub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YuXin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien M.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Poser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6304-9579","authenticated-orcid":false,"given":"Zipporiah","family":"Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7521-3279","authenticated-orcid":false,"given":"Atehsa","family":"Sahagun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianpu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8968-6461","authenticated-orcid":false,"given":"Samantha","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dena G.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin S.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Pochet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9213-8426","authenticated-orcid":false,"given":"Ezgi O.","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Blanchette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0135-0972","authenticated-orcid":false,"given":"Helen S.","family":"Bateup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4775-3515","authenticated-orcid":false,"given":"Donald C.","family":"Rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9358-8111","authenticated-orcid":false,"given":"Cornelis","family":"Blauwendraat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5598-5092","authenticated-orcid":false,"given":"Dirk","family":"Hockemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7102-8655","authenticated-orcid":false,"given":"Frank","family":"Soldner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"74355_CR1","unstructured":"Lewin Group. Economic Burden and Future Impact of Parkinson\u2019s Disease\u2014Final report. (The Michael J. Fox Foundation for Parkinson's Research, 2019)."},{"key":"74355_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2019.134316","volume":"709","author":"MX Henderson","year":"2019","unstructured":"Henderson, M. X., Trojanowski, J. Q. & Lee, V. M. Alpha-synuclein pathology in Parkinson\u2019s disease and related alpha-synucleinopathies. Neurosci. Lett. 709, 134316 (2019).","journal-title":"Neurosci. Lett."},{"key":"74355_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nm.4269","volume":"23","author":"YC Wong","year":"2017","unstructured":"Wong, Y. C. & Krainc, D. Alpha-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies. Nat. Med. 23, 1\u201313 (2017).","journal-title":"Nat. Med."},{"key":"74355_CR4","doi-asserted-by":"publisher","unstructured":"Blauwendraat, C., Nalls, M. A. & Singleton, A. B. The genetic architecture of Parkinson\u2019s disease. Lancet Neurol. https:\/\/doi.org\/10.1016\/s1474-4422(19)30287-x (2019).","DOI":"10.1016\/s1474-4422(19)30287-x"},{"key":"74355_CR5","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem, B. R., Okun, M. S. & Klein, C. Parkinson\u2019s disease. Lancet 397, 2284\u20132303 (2021).","journal-title":"Lancet"},{"key":"74355_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","volume":"9","author":"M Goedert","year":"2013","unstructured":"Goedert, M., Spillantini, M. G., Del Tredici, K. & Braak, H. 100 years of Lewy pathology. Nat. Rev. Neurol. 9, 13\u201324 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"74355_CR7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41531-019-0076-6","volume":"5","author":"RH Reynolds","year":"2019","unstructured":"Reynolds, R. H. et al. Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson\u2019s disease heritability. NPJ Parkinsons Dis. 5, 6 (2019).","journal-title":"NPJ Parkinsons Dis."},{"key":"74355_CR8","doi-asserted-by":"publisher","unstructured":"Panicker, N., Ge, P., Dawson, V. L. & Dawson, T. M. The cell biology of Parkinson\u2019s disease. J. Cell Biol. 220, https:\/\/doi.org\/10.1083\/jcb.202012095 (2021).","DOI":"10.1083\/jcb.202012095"},{"key":"74355_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.1023574","volume":"14","author":"J Dulski","year":"2022","unstructured":"Dulski, J., Uitti, R. J., Ross, O. A. & Wszolek, Z. K. Genetic architecture of Parkinson\u2019s disease subtypes\u2014review of the literature. Front. Aging Neurosci. 14, 1023574 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"74355_CR10","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.cell.2011.06.019","volume":"146","author":"F Soldner","year":"2011","unstructured":"Soldner, F. et al. Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell 146, 318\u2013331 (2011).","journal-title":"Cell"},{"key":"74355_CR11","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.cell.2018.09.010","volume":"175","author":"F Soldner","year":"2018","unstructured":"Soldner, F. & Jaenisch, R. Stem cells, genome editing, and the path to translational medicine. Cell 175, 615\u2013632 (2018).","journal-title":"Cell"},{"key":"74355_CR12","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.stem.2016.04.013","volume":"18","author":"D Hockemeyer","year":"2016","unstructured":"Hockemeyer, D. & Jaenisch, R. Induced pluripotent stem cells meet genome editing. Cell Stem Cell 18, 573\u2013586 (2016).","journal-title":"Cell Stem Cell"},{"key":"74355_CR13","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1016\/j.celrep.2018.05.009","volume":"23","author":"DC Schondorf","year":"2018","unstructured":"Schondorf, D. C. et al. The NAD+ precursor nicotinamide riboside rescues mitochondrial defects and neuronal loss in iPSC and fly models of Parkinson\u2019s disease. Cell Rep. 23, 2976\u20132988 (2018).","journal-title":"Cell Rep."},{"key":"74355_CR14","doi-asserted-by":"publisher","first-page":"14280","DOI":"10.1073\/pnas.1900576116","volume":"116","author":"C Czaniecki","year":"2019","unstructured":"Czaniecki, C. et al. Axonal pathology in hPSC-based models of Parkinson\u2019s disease results from loss of Nrf2 transcriptional activity at the Map1b gene locus. Proc. Natl. Acad. Sci. USA 116, 14280\u201314289 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74355_CR15","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.tins.2022.05.001","volume":"45","author":"A Bose","year":"2022","unstructured":"Bose, A., Petsko, G. A. & Studer, L. Induced pluripotent stem cells: a tool for modeling Parkinson\u2019s disease. Trends Neurosci. 45, 608\u2013620 (2022).","journal-title":"Trends Neurosci."},{"key":"74355_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2021.102354","volume":"53","author":"A Beylina","year":"2021","unstructured":"Beylina, A., Langston, R. G., Rosen, D., Reed, X. & Cookson, M. R. Generation of fourteen isogenic cell lines for Parkinson\u2019s disease-associated leucine-rich repeat kinase (LRRK2). Stem Cell Res. 53, 102354 (2021).","journal-title":"Stem Cell Res."},{"key":"74355_CR17","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1016\/j.cell.2022.05.008","volume":"185","author":"E Hallacli","year":"2022","unstructured":"Hallacli, E. et al. The Parkinson\u2019s disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability. Cell 185, 2035\u20132056 (2022).","journal-title":"Cell"},{"key":"74355_CR18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.nbd.2013.10.013","volume":"62","author":"LH Sanders","year":"2014","unstructured":"Sanders, L. H. et al. LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson\u2019s disease patients: reversal by gene correction. Neurobiol. Dis. 62, 381\u2013386 (2014).","journal-title":"Neurobiol. Dis."},{"key":"74355_CR19","doi-asserted-by":"crossref","unstructured":"Chen, X.-Q. C. & Deneault E. et al. Generation of patient-derived pluripotent stem cell-lines and CRISPR modified isogenic controls with mutations in the Parkinson\u2019s associated GBA gene. Stem Cell Res. 64, 102919 (2022).","DOI":"10.1016\/j.scr.2022.102919"},{"key":"74355_CR20","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.stemcr.2015.02.019","volume":"4","author":"A ShaltoGWASi","year":"2015","unstructured":"ShaltoGWASi, A. et al. Mitochondrial alterations by PARKIN in dopaminergic neurons using PARK2 patient-specific and PARK2 knockout isogenic iPSC lines. Stem Cell Rep. 4, 847\u2013859 (2015).","journal-title":"Stem Cell Rep."},{"key":"74355_CR21","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.stemcr.2018.09.006","volume":"11","author":"Y Tabata","year":"2018","unstructured":"Tabata, Y. et al. T-type calcium channels determine the vulnerability of dopaminergic neurons to mitochondrial stress in familial Parkinson disease. Stem Cell Rep. 11, 1171\u20131184 (2018).","journal-title":"Stem Cell Rep."},{"key":"74355_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5028","volume":"5","author":"DC Schondorf","year":"2014","unstructured":"Schondorf, D. C. et al. iPSC-derived neurons from GBA1-associated Parkinson\u2019s disease patients show autophagic defects and impaired calcium homeostasis. Nat. Commun. 5, 4028 (2014).","journal-title":"Nat. Commun."},{"key":"74355_CR23","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.stem.2013.01.008","volume":"12","author":"P Reinhardt","year":"2013","unstructured":"Reinhardt, P. et al. Genetic correction of a LRRK2 mutation in human iPSCs links Parkinsonian neurodegeneration to ERK-dependent changes in gene expression. Cell Stem Cell 12, 354\u2013367 (2013).","journal-title":"Cell Stem Cell"},{"key":"74355_CR24","doi-asserted-by":"publisher","unstructured":"Guttikonda, S. R. et al. Fully defined human pluripotent stem cell-derived microglia and tri-culture system model C3 production in Alzheimer\u2019s disease. Nat. Neurosci. https:\/\/doi.org\/10.1038\/s41593-020-00796-z (2021).","DOI":"10.1038\/s41593-020-00796-z"},{"key":"74355_CR25","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.stemcr.2013.08.001","volume":"1","author":"H Fong","year":"2013","unstructured":"Fong, H. et al. Genetic correction of tauopathy phenotypes in neurons derived from human induced pluripotent stem cells. Stem Cell Rep. 1, 226\u2013234 (2013).","journal-title":"Stem Cell Rep."},{"key":"74355_CR26","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1126\/science.aam9080","volume":"357","author":"LF Burbulla","year":"2017","unstructured":"Burbulla, L. F. et al. Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease. Science 357, 1255\u20131261 (2017).","journal-title":"Science"},{"key":"74355_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2023.103125","volume":"69","author":"N Kozhushko","year":"2023","unstructured":"Kozhushko, N., Beilina, A. & Cookson, M. R. Generation of gene-corrected isogenic controls from Parkinson\u2019s disease patient iPSC lines carrying the pathogenic SNCA p.A53T variant. Stem Cell Res. 69, 103125 (2023).","journal-title":"Stem Cell Res."},{"key":"74355_CR28","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.molcel.2018.11.028","volume":"73","author":"S Fanning","year":"2019","unstructured":"Fanning, S. et al. Lipidomic analysis of alpha-synuclein neurotoxicity identifies stearoyl CoA desaturase as a target for Parkinson treatment. Mol. Cell 73, 1001\u20131014 (2019).","journal-title":"Mol. Cell"},{"key":"74355_CR29","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1126\/science.1245296","volume":"342","author":"CY Chung","year":"2013","unstructured":"Chung, C. Y. et al. Identification and rescue of alpha-synuclein toxicity in Parkinson patient-derived neurons. Science 342, 983\u2013987 (2013).","journal-title":"Science"},{"key":"74355_CR30","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.cell.2013.11.009","volume":"155","author":"SD Ryan","year":"2013","unstructured":"Ryan, S. D. et al. Isogenic human iPSC Parkinson\u2019s model shows nitrosative stress-induced dysfunction in MEF2-PGC1alpha transcription. Cell 155, 1351\u20131364 (2013).","journal-title":"Cell"},{"key":"74355_CR31","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.stem.2022.11.006","volume":"29","author":"PW Andrews","year":"2022","unstructured":"Andrews, P. W. et al. The consequences of recurrent genetic and epigenetic variants in human pluripotent stem cells. Cell Stem Cell 29, 1624\u20131636 (2022).","journal-title":"Cell Stem Cell"},{"key":"74355_CR32","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nbt.2673","volume":"31","author":"V Pattanayak","year":"2013","unstructured":"Pattanayak, V. et al. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat. Biotechnol. 31, 839\u2013843 (2013).","journal-title":"Nat. Biotechnol."},{"key":"74355_CR33","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nbt.2623","volume":"31","author":"Y Fu","year":"2013","unstructured":"Fu, Y. et al. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat. Biotechnol. 31, 822\u2013826 (2013).","journal-title":"Nat. Biotechnol."},{"key":"74355_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16323-4","volume":"11","author":"E Kuijk","year":"2020","unstructured":"Kuijk, E. et al. The mutational impact of culturing human pluripotent and adult stem cells. Nat. Commun. 11, 2493 (2020).","journal-title":"Nat. Commun."},{"key":"74355_CR35","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1089\/crispr.2022.0050","volume":"6","author":"A Panda","year":"2023","unstructured":"Panda, A. et al. Clonally selected lines after CRISPR-Cas editing are not isogenic. CRISPR J. 6, 176\u2013182 (2023).","journal-title":"CRISPR J."},{"key":"74355_CR36","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/j.stem.2022.11.004","volume":"29","author":"CB Pantazis","year":"2022","unstructured":"Pantazis, C. B. et al. A reference human induced pluripotent stem cell line for large-scale collaborative studies. Cell Stem Cell 29, 1685\u20131702 (2022).","journal-title":"Cell Stem Cell"},{"key":"74355_CR37","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.cell.2010.04.010","volume":"141","author":"CJ Lengner","year":"2010","unstructured":"Lengner, C. J. et al. Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations. Cell 141, 872\u2013883 (2010).","journal-title":"Cell"},{"key":"74355_CR38","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.stem.2013.07.001","volume":"13","author":"G Liang","year":"2013","unstructured":"Liang, G. & Zhang, Y. Genetic and epigenetic variations in iPSCs: potential causes and implications for application. Cell Stem Cell 13, 149\u2013159 (2013).","journal-title":"Cell Stem Cell"},{"key":"74355_CR39","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.celrep.2017.04.020","volume":"19","author":"S Bar","year":"2017","unstructured":"Bar, S., Schachter, M., Eldar-Geva, T. & Benvenisty, N. Large-scale analysis of loss of imprinting in human pluripotent stem cells. Cell Rep. 19, 957\u2013968 (2017).","journal-title":"Cell Rep."},{"key":"74355_CR40","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nature17939","volume":"533","author":"F Soldner","year":"2016","unstructured":"Soldner, F. et al. Parkinson-associated risk variant in distal enhancer of alpha-synuclein modulates target gene expression. Nature 533, 95\u201399 (2016).","journal-title":"Nature"},{"key":"74355_CR41","doi-asserted-by":"publisher","unstructured":"Krzisch, M. et al. The A53T mutation in alpha-synuclein enhances proinflammatory activation in human microglia upon inflammatory stimulus. Biol. Psychiatry, https:\/\/doi.org\/10.1016\/j.biopsych.2024.07.011 (2024).","DOI":"10.1016\/j.biopsych.2024.07.011"},{"key":"74355_CR42","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.celrep.2018.09.032","volume":"25","author":"A Omer Javed","year":"2018","unstructured":"Omer Javed, A. et al. Microcephaly modeling of kinetochore mutation reveals a brain-specific phenotype. Cell Rep. 25, 368\u2013382 (2018).","journal-title":"Cell Rep."},{"key":"74355_CR43","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1182\/blood.2021013750","volume":"140","author":"S Choo","year":"2022","unstructured":"Choo, S. et al. Editing TINF2 as a potential therapeutic approach to restore telomere length in dyskeratosis congenita. Blood 140, 608\u2013618 (2022).","journal-title":"Blood"},{"key":"74355_CR44","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1126\/science.aao0535","volume":"357","author":"K Chiba","year":"2017","unstructured":"Chiba, K. et al. Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism. Science 357, 1416\u20131420 (2017).","journal-title":"Science"},{"key":"74355_CR45","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1038\/s41591-018-0139-y","volume":"24","author":"JD Blair","year":"2018","unstructured":"Blair, J. D., Hockemeyer, D. & Bateup, H. S. Genetically engineered human cortical spheroid models of tuberous sclerosis. Nat. Med. 24, 1568\u20131578 (2018).","journal-title":"Nat. Med."},{"key":"74355_CR46","doi-asserted-by":"crossref","unstructured":"Bandres-Ciga, S. et al. NeuroBooster Array: A Genome-Wide Genotyping Platform to Study Neurological Disorders Across Diverse Populations. Mov Disord 39, 2039\u20132048 (2024).","DOI":"10.1002\/mds.29902"},{"key":"74355_CR47","doi-asserted-by":"publisher","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","volume":"42","author":"MJ Landrum","year":"2014","unstructured":"Landrum, M. J. et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 42, D980\u2013D985 (2014).","journal-title":"Nucleic Acids Res."},{"key":"74355_CR48","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1038\/s41592-023-01993-x","volume":"20","author":"M Kolmogorov","year":"2023","unstructured":"Kolmogorov, M. et al. Scalable nanopore sequencing of human genomes provides a comprehensive view of haplotype-resolved variation and methylation. Nat. Methods 20, 1483\u20131492 (2023).","journal-title":"Nat. Methods"},{"key":"74355_CR49","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41586-023-05896-x","volume":"617","author":"WW Liao","year":"2023","unstructured":"Liao, W. W. et al. A draft human pangenome reference. Nature 617, 312\u2013324 (2023).","journal-title":"Nature"},{"key":"74355_CR50","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls, M. A. et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies.  Lancet Neurol. 18, 1091\u20131102 (2019).","journal-title":"Lancet Neurol."},{"key":"74355_CR51","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez, C. et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat. Genet. 54, 412\u2013436 (2022).","journal-title":"Nat. Genet."},{"key":"74355_CR52","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens, P. et al. Alzheimer\u2019s disease. Lancet 397, 1577\u20131590 (2021).","journal-title":"Lancet"},{"key":"74355_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-022-01046-6","volume":"14","author":"D Danis","year":"2022","unstructured":"Danis, D. et al. SvAnna: efficient and accurate pathogenicity prediction of coding and regulatory structural variants in long-read genome sequencing. Genome Med. 14, 44 (2022).","journal-title":"Genome Med."},{"key":"74355_CR54","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek, M. et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285\u2013291 (2016).","journal-title":"Nature"},{"key":"74355_CR55","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","volume":"625","author":"S Chen","year":"2024","unstructured":"Chen, S. et al. A genomic mutational constraint map using variation in 76,156 human genomes. Nature 625, 92\u2013100 (2024).","journal-title":"Nature"},{"key":"74355_CR56","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.ejmg.2017.09.004","volume":"60","author":"RM Kisla Ekinci","year":"2017","unstructured":"Kisla Ekinci, R. M., Balci, S., Bisgin, A., Altintas, D. U. & Yilmaz, M. A homozygote TREX1 mutation in two siblings with different phenotypes: chilblains and cerebral vasculitis. Eur. J. Med. Genet. 60, 690\u2013694 (2017).","journal-title":"Eur. J. Med. Genet."},{"key":"74355_CR57","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","volume":"99","author":"NM Ioannidis","year":"2016","unstructured":"Ioannidis, N. M. et al. REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am. J. Hum. Genet. 99, 877\u2013885 (2016).","journal-title":"Am. J. Hum. Genet."},{"key":"74355_CR58","doi-asserted-by":"publisher","first-page":"D886","DOI":"10.1093\/nar\/gky1016","volume":"47","author":"P Rentzsch","year":"2019","unstructured":"Rentzsch, P., Witten, D., Cooper, G. M., Shendure, J. & Kircher, M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 47, D886\u2013D894 (2019).","journal-title":"Nucleic Acids Res."},{"key":"74355_CR59","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"CC Liu","year":"2013","unstructured":"Liu, C. C., Liu, C. C., Kanekiyo, T., Xu, H. & Bu, G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat. Rev. Neurol. 9, 106\u2013118 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"74355_CR60","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/ng.536","volume":"42","author":"VM Van Deerlin","year":"2010","unstructured":"Van Deerlin, V. M. et al. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat. Genet. 42, 234\u2013239 (2010).","journal-title":"Nat. Genet."},{"key":"74355_CR61","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/ng.487","volume":"41","author":"J Simon-Sanchez","year":"2009","unstructured":"Simon-Sanchez, J. et al. Genome-wide association study reveals genetic risk underlying Parkinson\u2019s disease. Nat. Genet. 41, 1308\u20131312 (2009).","journal-title":"Nat. Genet."},{"key":"74355_CR62","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/s41374-019-0197-x","volume":"99","author":"KH Strang","year":"2019","unstructured":"Strang, K. H., Golde, T. E. & Giasson, B. I. MAPT mutations, tauopathy, and mechanisms of neurodegeneration. Lab. Investig. 99, 912\u2013928 (2019).","journal-title":"Lab. Investig."},{"key":"74355_CR63","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/s41591-018-0050-6","volume":"24","author":"RJ Ihry","year":"2018","unstructured":"Ihry, R. J. et al. p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells. Nat. Med. 24, 939\u2013946 (2018).","journal-title":"Nat. Med."},{"key":"74355_CR64","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/s41591-018-0049-z","volume":"24","author":"E Haapaniemi","year":"2018","unstructured":"Haapaniemi, E., Botla, S., Persson, J., Schmierer, B. & Taipale, J. CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response. Nat. Med. 24, 927\u2013930 (2018).","journal-title":"Nat. Med."},{"key":"74355_CR65","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nature22312","volume":"545","author":"FT Merkle","year":"2017","unstructured":"Merkle, F. T. et al. Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations. Nature 545, 229\u2013233 (2017).","journal-title":"Nature"},{"key":"74355_CR66","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.stem.2021.01.005","volume":"28","author":"TW Kim","year":"2021","unstructured":"Kim, T. W. et al. Biphasic activation of WNT signaling facilitates the derivation of midbrain dopamine neurons from hESCs for translational use. Cell Stem Cell 28, 343\u2013355 (2021).","journal-title":"Cell Stem Cell"},{"key":"74355_CR67","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.stem.2021.01.004","volume":"28","author":"J Piao","year":"2021","unstructured":"Piao, J. et al. Preclinical efficacy and safety of a human embryonic stem cell-derived midbrain dopamine progenitor product, MSK-DA01. Cell Stem Cell 28, 217\u2013229 (2021).","journal-title":"Cell Stem Cell"},{"key":"74355_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108263","volume":"33","author":"HJR Fernandes","year":"2020","unstructured":"Fernandes, H. J. R. et al. Single-cell transcriptomics of Parkinson\u2019s disease human in vitro models reveals dopamine neuron-specific stress responses. Cell Rep. 33, 108263 (2020).","journal-title":"Cell Rep."},{"key":"74355_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2023.100261","volume":"3","author":"E Bressan","year":"2023","unstructured":"Bressan, E. et al. The foundational data initiative for Parkinson disease: enabling efficient translation from genetic maps to mechanism. Cell Genom. 3, 100261 (2023).","journal-title":"Cell Genom."},{"key":"74355_CR70","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1002\/ana.26032","volume":"89","author":"MS Andersen","year":"2021","unstructured":"Andersen, M. S. et al. Heritability enrichment implicates microglia in Parkinson\u2019s disease pathogenesis. Ann. Neurol. 89, 942\u2013951 (2021).","journal-title":"Ann. Neurol."},{"key":"74355_CR71","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abp8869","volume":"14","author":"RG Langston","year":"2022","unstructured":"Langston, R. G. et al. Association of a common genetic variant with Parkinson\u2019s disease is mediated by microglia. Sci. Transl. Med. 14, eabp8869 (2022).","journal-title":"Sci. Transl. Med."},{"key":"74355_CR72","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41583-018-0055-7","volume":"19","author":"MT Heneka","year":"2018","unstructured":"Heneka, M. T., McManus, R. M. & Latz, E. Inflammasome signalling in brain function and neurodegenerative disease. Nat. Rev. Neurosci. 19, 610\u2013621 (2018).","journal-title":"Nat. Rev. Neurosci."},{"key":"74355_CR73","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/j.stemcr.2017.04.023","volume":"8","author":"P Douvaras","year":"2017","unstructured":"Douvaras, P. et al. Directed differentiation of human pluripotent stem cells to microglia. Stem Cell Rep. 8, 1516\u20131524 (2017).","journal-title":"Stem Cell Rep."},{"key":"74355_CR74","doi-asserted-by":"publisher","unstructured":"Li, H. et al. Highly efficient generation of isogenic pluripotent stem cell models using prime editing. Elife 11, https:\/\/doi.org\/10.7554\/eLife.79208 (2022).","DOI":"10.7554\/eLife.79208"},{"key":"74355_CR75","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nbt.1927","volume":"29","author":"D Hockemeyer","year":"2011","unstructured":"Hockemeyer, D. et al. Genetic engineering of human pluripotent cells using TALE nucleases. Nat. Biotechnol. 29, 731\u2013734 (2011).","journal-title":"Nat. Biotechnol."},{"key":"74355_CR76","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/mds.26651","volume":"31","author":"CM Lill","year":"2016","unstructured":"Lill, C. M. et al. Launching the movement disorders society genetic mutation database (MDSGene). Mov. Disord. 31, 607\u2013609 (2016).","journal-title":"Mov. Disord."},{"key":"74355_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15271-3","volume":"11","author":"O Thompson","year":"2020","unstructured":"Thompson, O. et al. Low rates of mutation in clinical grade human pluripotent stem cells under different culture conditions. Nat. Commun. 11, 1528 (2020).","journal-title":"Nat. Commun."},{"key":"74355_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.stemcr.2017.05.029","volume":"9","author":"PW Andrews","year":"2017","unstructured":"Andrews, P. W. et al. Assessing the safety of human pluripotent stem cells and their derivatives for clinical applications. Stem Cell Rep. 9, 1\u20134 (2017).","journal-title":"Stem Cell Rep."},{"key":"74355_CR79","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nbt.1615","volume":"28","author":"E Narva","year":"2010","unstructured":"Narva, E. et al. High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nat. Biotechnol. 28, 371\u2013377 (2010).","journal-title":"Nat. Biotechnol."},{"key":"74355_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107689","volume":"31","author":"I Weisheit","year":"2020","unstructured":"Weisheit, I. et al. Detection of deleterious on-target effects after HDR-mediated CRISPR editing. Cell Rep. 31, 107689 (2020).","journal-title":"Cell Rep."},{"key":"74355_CR81","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1126\/science.aab4082","volume":"349","author":"I Martincorena","year":"2015","unstructured":"Martincorena, I. & Campbell, P. J. Somatic mutation in cancer and normal cells. Science 349, 1483\u20131489 (2015).","journal-title":"Science"},{"key":"74355_CR82","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/s41592-023-01859-2","volume":"20","author":"SQ Liang","year":"2023","unstructured":"Liang, S. Q. et al. Genome-wide profiling of prime editor off-target sites in vitro and in vivo using PE-tag. Nat. Methods 20, 898\u2013907 (2023).","journal-title":"Nat. Methods"},{"key":"74355_CR83","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/nbt.4235","volume":"36","author":"R Poplin","year":"2018","unstructured":"Poplin, R. et al. A universal SNP and small-indel variant caller using deep neural networks. Nat. Biotechnol. 36, 983\u2013987 (2018).","journal-title":"Nat. Biotechnol."},{"key":"74355_CR84","doi-asserted-by":"publisher","first-page":"5582","DOI":"10.1093\/bioinformatics\/btaa1081","volume":"36","author":"T Yun","year":"2021","unstructured":"Yun, T. et al. Accurate, scalable cohort variant calls using DeepVariant and GLnexus. Bioinformatics 36, 5582\u20135589 (2021).","journal-title":"Bioinformatics"},{"key":"74355_CR85","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.neurobiolaging.2022.07.012","volume":"119","author":"J Hu","year":"2022","unstructured":"Hu, J. et al. Gene-based burden analysis of damaging private variants in PRKN, PARK7 and PINK1 in Parkinson\u2019s disease cohorts of European descent. Neurobiol. Aging 119, 136\u2013138 (2022).","journal-title":"Neurobiol. Aging"},{"key":"74355_CR86","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/bioinformatics\/btu048","volume":"30","author":"S Bae","year":"2014","unstructured":"Bae, S., Park, J. & Kim, J. S. Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics 30, 1473\u20131475 (2014).","journal-title":"Bioinformatics"},{"key":"74355_CR87","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"C Genomes Project","year":"2015","unstructured":"Genomes Project, C. et al. A global reference for human genetic variation. Nature 526, 68\u201374 (2015).","journal-title":"Nature"},{"key":"74355_CR88","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1091\/mbc.E19-08-0447","volume":"31","author":"JM Boyle","year":"2020","unstructured":"Boyle, J. M. et al. Telomere length set point regulation in human pluripotent stem cells critically depends on the shelterin protein TPP1. Mol. Biol. Cell 31, 2583\u20132596 (2020).","journal-title":"Mol. Biol. Cell"},{"key":"74355_CR89","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","volume":"576","author":"AV Anzalone","year":"2019","unstructured":"Anzalone, A. V. et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576, 149\u2013157 (2019).","journal-title":"Nature"},{"key":"74355_CR90","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.stemcr.2023.08.003","volume":"18","author":"TE Ludwig","year":"2023","unstructured":"Ludwig, T. E. et al. ISSCR standards for the use of human stem cells in basic research. Stem Cell Rep. 18, 1744\u20131752 (2023).","journal-title":"Stem Cell Rep."},{"key":"74355_CR91","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.celrep.2019.03.019","volume":"27","author":"S Bar","year":"2019","unstructured":"Bar, S., Seaton, L. R., Weissbein, U., Eldar-Geva, T. & Benvenisty, N. Global characterization of X chromosome inactivation in human pluripotent stem cells. Cell Rep. 27, 20\u201329 (2019).","journal-title":"Cell Rep."},{"key":"74355_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109215","volume":"35","author":"P Bansal","year":"2021","unstructured":"Bansal, P., Ahern, D. T., Kondaveeti, Y., Qiu, C. W. & Pinter, S. F. Contiguous erosion of the inactive X in human pluripotency concludes with global DNA hypomethylation. Cell Rep. 35, 109215 (2021).","journal-title":"Cell Rep."},{"key":"74355_CR93","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.stem.2015.03.016","volume":"16","author":"C Vallot","year":"2015","unstructured":"Vallot, C. et al. Erosion of X chromosome inactivation in human pluripotent cells initiates with XACT coating and depends on a specific heterochromatin landscape. Cell Stem Cell 16, 533\u2013546 (2015).","journal-title":"Cell Stem Cell"},{"key":"74355_CR94","doi-asserted-by":"publisher","unstructured":"Lee, Y. J. et al. Alternative pre-mRNA splicing and gene expression patterns in midbrain lineage cells carrying familial Parkinson\u2019s disease mutations. Preprint at bioRxiv, https:\/\/doi.org\/10.1101\/2024.02.28.582420 (2025).","DOI":"10.1101\/2024.02.28.582420"},{"key":"74355_CR95","doi-asserted-by":"publisher","unstructured":"Brenton, J. W. et al. TDP-43 loss of function drives aberrant splicing in Parkinson\u2019s disease. bioRxiv, 2025.2009.2004.673943 https:\/\/doi.org\/10.1101\/2025.09.04.673943 (2025).","DOI":"10.1101\/2025.09.04.673943"},{"key":"74355_CR96","doi-asserted-by":"publisher","DOI":"10.1186\/s13742-015-0047-8","volume":"4","author":"CC Chang","year":"2015","unstructured":"Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4, 7 (2015).","journal-title":"Gigascience"},{"key":"74355_CR97","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1093\/bioinformatics\/bts610","volume":"28","author":"SM Gogarten","year":"2012","unstructured":"Gogarten, S. M. et al. cas-off: an R\/Bioconductor package for quality control and analysis of genome-wide association studies. Bioinformatics 28, 3329\u20133331 (2012).","journal-title":"Bioinformatics"},{"key":"74355_CR98","doi-asserted-by":"publisher","unstructured":"Danecek, P. et al. Twelve years of SAMtools and BCFtools. Gigascience 10, https:\/\/doi.org\/10.1093\/gigascience\/giab008 (2021).","DOI":"10.1093\/gigascience\/giab008"},{"key":"74355_CR99","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1093\/bioinformatics\/bty191","volume":"34","author":"H Li","year":"2018","unstructured":"Li, H. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics 34, 3094\u20133100 (2018).","journal-title":"Bioinformatics"},{"key":"74355_CR100","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s41592-021-01299-w","volume":"18","author":"K Shafin","year":"2021","unstructured":"Shafin, K. et al. Haplotype-aware variant calling with PEPPER-Margin-DeepVariant enables high accuracy in nanopore long-reads. Nat. Methods 18, 1322\u20131332 (2021).","journal-title":"Nat. Methods"},{"key":"74355_CR101","doi-asserted-by":"publisher","unstructured":"Razaghi, R. et al. Preprint at bioRxiv, https:\/\/doi.org\/10.1101\/2022.07.07.499188 (2022).","DOI":"10.1101\/2022.07.07.499188"},{"key":"74355_CR102","doi-asserted-by":"publisher","unstructured":"Smolka, M. et al. Detection of mosaic and population-level structural variants with Sniffles2. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/s41587-023-02024-y (2024).","DOI":"10.1038\/s41587-023-02024-y"},{"key":"74355_CR103","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164 (2010).","journal-title":"Nucleic Acids Res."},{"key":"74355_CR104","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/nar\/29.1.308","volume":"29","author":"ST Sherry","year":"2001","unstructured":"Sherry, S. T. et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29, 308\u2013311 (2001).","journal-title":"Nucleic Acids Res."},{"key":"74355_CR105","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-020-00803-9","volume":"12","author":"X Liu","year":"2020","unstructured":"Liu, X., Li, C., Mou, C., Dong, Y. & Tu, Y. dbNSFP v4: a comprehensive database of transcript-specific functional predictions and annotations for human nonsynonymous and splice-site SNVs. Genome Med. 12, 103 (2020).","journal-title":"Genome Med."},{"key":"74355_CR106","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum, M. J. et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 46, D1062\u2013D1067 (2018).","journal-title":"Nucleic Acids Res."},{"key":"74355_CR107","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMsr1406261","volume":"372","author":"HL Rehm","year":"2015","unstructured":"Rehm, H. L. et al. ClinGen-the Clinical Genome Resource. New Engl. J. Med. 372, 2235\u20132242 (2015).","journal-title":"New Engl. J. Med."},{"key":"74355_CR108","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41436-019-0686-8","volume":"22","author":"ER Riggs","year":"2020","unstructured":"Riggs, E. R. et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet. Med. 22, 245\u2013257 (2020).","journal-title":"Genet. Med."},{"key":"74355_CR109","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51, D587\u2013D592 (2023).","journal-title":"Nucleic Acids Res."},{"key":"74355_CR110","doi-asserted-by":"publisher","first-page":"D1207","DOI":"10.1093\/nar\/gkaa1043","volume":"49","author":"S Kohler","year":"2021","unstructured":"Kohler, S. et al. The human phenotype ontology in 2021. Nucleic Acids Res. 49, D1207\u2013D1217 (2021).","journal-title":"Nucleic Acids Res."},{"key":"74355_CR111","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database (MSigDB) Hallmark Gene Set Collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"74355_CR112","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 1739\u20131740 (2011).","journal-title":"Bioinformatics"},{"key":"74355_CR113","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74355_CR114","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle, B. W. et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat. Genet. 51, 414\u2013430 (2019).","journal-title":"Nat. Genet."},{"key":"74355_CR115","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203\u2013209 (2018).","journal-title":"Nature"},{"key":"74355_CR116","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-022-02840-6","volume":"23","author":"AC English","year":"2022","unstructured":"English, A. C., Menon, V. K., Gibbs, R. A., Metcalf, G. A. & Sedlazeck, F. J. Truvari: refined structural variant comparison preserves allelic diversity. Genome Biol. 23, 271 (2022).","journal-title":"Genome Biol."},{"key":"74355_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06159-4","volume":"9","author":"AA Regier","year":"2018","unstructured":"Regier, A. A. et al. Functional equivalence of genome sequencing analysis pipelines enables harmonized variant calling across human genetics projects. Nat. Commun. 9, 4038 (2018).","journal-title":"Nat. Commun."},{"key":"74355_CR118","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1093\/bioinformatics\/btu168","volume":"30","author":"V Obenchain","year":"2014","unstructured":"Obenchain, V. et al. VariantAnnotation: a Bioconductor package for exploration and annotation of genetic variants. Bioinformatics 30, 2076\u20132078 (2014).","journal-title":"Bioinformatics"},{"key":"74355_CR119","unstructured":"Gkanogiannis, A. fastreeR: Phylogenetic, Distance and Other Calculations on VCF and Fasta Files, Vol. 1.10.0 (Bioconductor, 2024)."},{"key":"74355_CR120","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/bioinformatics\/bty633","volume":"35","author":"E Paradis","year":"2019","unstructured":"Paradis, E. & Schliep, K. ape 5.0: an environment for modern phylogenetics and evolutionary analyses in R. Bioinformatics 35, 526\u2013528 (2019).","journal-title":"Bioinformatics"},{"key":"74355_CR121","unstructured":"Green, M. R. & Sambrook, J. Molecular Cloning: A Laboratory Manual,4th edn. (Cold Spring Harbor Laboratory Press, 2012)."},{"key":"74355_CR122","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature14592","volume":"523","author":"BP Kleinstiver","year":"2015","unstructured":"Kleinstiver, B. P. et al. Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature 523, 481\u2013485 (2015).","journal-title":"Nature"},{"key":"74355_CR123","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","volume":"37","author":"K Clement","year":"2019","unstructured":"Clement, K. et al. CRISPResso2 provides accurate and rapid genome editing sequence analysis. Nat. Biotechnol. 37, 224\u2013226 (2019).","journal-title":"Nat. Biotechnol."},{"key":"74355_CR124","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.3415","volume":"12","author":"AM Pasca","year":"2015","unstructured":"Pasca, A. M. et al. Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture. Nat. Methods 12, 671\u2013678 (2015).","journal-title":"Nat. Methods"},{"key":"74355_CR125","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41592-018-0255-0","volume":"16","author":"SJ Yoon","year":"2019","unstructured":"Yoon, S. J. et al. Reliability of human cortical organoid generation. Nat. Methods 16, 75\u201378 (2019).","journal-title":"Nat. Methods"},{"key":"74355_CR126","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41592-019-0433-8","volume":"16","author":"CS McGinnis","year":"2019","unstructured":"McGinnis, C. S. et al. MULTI-seq: sample multiplexing for single-cell RNA sequencing using lipid-tagged indices. Nat. Methods 16, 619\u2013626 (2019).","journal-title":"Nat. Methods"},{"key":"74355_CR127","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587 (2021).","journal-title":"Cell"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74355-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74355-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74355-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:04:48Z","timestamp":1785755088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74355-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":127,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["74355"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-74355-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"10 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"7682"}}